Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices
Andreea Neblea
From Bedfont® Scientific Ltd Oct 14 2025 Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyou investments, today announced it has acquired a majority stake in Bedfont ® Scientific Ltd. (“Bedfont”), which designs and manufactures non-invasive breath analysis medical devices. As part of the transaction, the Company’s existing shareholders will reinvest alongside Keensight. Founded in 1976 and headquartered in Maidstone, UK, Bedfont is
din zilele anterioare